This PDF is the current document as it appeared on Public Inspection on 09/05/2014 at 08:45 am.
Food and Drug Administration, HHS.
Final rule; corrections.
The Food and Drug Administration (FDA) is correcting a document entitled “Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements; Correction” that appeared in the Federal Register of August 14, 2014 (79 FR 47655). The document published without the required RIN number and in the Notice category. This document corrects those errors.
Effective Date: September 8, 2014.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Jean Chung, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 4466, Silver Spring, MD 20993-0002, 301-796-1874; or Stephen Ripley, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7268, Silver Spring, MD 20993-0002, 240-402-7911.End Further Info End Preamble Start Supplemental Information
In the Federal Register of August 14, 2014, in FR Doc. 2014-19255, the following correction is made:
1. On page 47655, in the first column, add the heading “RIN 0910-AF96” between the Docket No. and the title of the document.Start Signature
Dated: September 2, 2014.
Assistant Commissioner for Policy.
[FR Doc. 2014-21267 Filed 9-5-14; 8:45 am]
BILLING CODE 4164-01-P